Substance Use Disorder-Related Deaths and Maternal Mortality in New Mexico, 2015-2019

被引:1
|
作者
Fuchs, Jessica R. [1 ]
Schiff, Melissa A. [2 ]
Coronado, Eirian [1 ]
机构
[1] New Mexico Dept Hlth, 2040 S Pacheco St, Santa Fe, NM 87505 USA
[2] Univ New Mexico, Dept Internal Med, Sch Med, 1 Univ New Mexico, Albuquerque, NM 87131 USA
关键词
Maternal mortality; Substance use; Mental health; Pregnancy; Postpartum; RELAPSE; WOMEN;
D O I
10.1007/s10995-023-03691-8
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
BackgroundIn recent decades, maternal mortality has increased across the U.S. Experiences of pregnant and postpartum people with Substance Use Disorder (SUD)-related deaths have not been previously evaluated in New Mexico. The aim of this study was to analyze risk factors related to substance use and explore substance use patterns among pregnancy-associated deaths in New Mexico from 2015 to 2019.MethodsWe conducted an analysis of pregnancy-associated deaths to assess the association between demographics, pregnancy factors, circumstances surrounding death, treatment of mental health conditions, and experiences with social stressors among Substance Use Disorder (SUD)-related and non-SUD-related deaths. We performed univariate analyses of risk factors using chi-square tests to assess the differences between SUD-related and non-SUD-related deaths. We also examined substance use at time of death.ResultsPeople with SUD-related deaths were more likely to die 43-365 days postpartum (81% vs. 45%, p-value = 0.002), have had a primary cause of death of mental health conditions (47% vs 10%, p < 0.001), have died of an overdose (41% vs. 8%, p-value = 0.002), have had experienced any social stressors (86% vs 30%, p < 0.001) compared to people with non-SUD-related deaths, and received treatment for SUD at any point before, during, or after pregnancy (49% vs. 2%, p < 0.001). The substances most used at time of death were amphetamines (70%), and most cases engaged in polysubstance use (63%).Conclusions for PracticeProviders, health departments, and community organizations must prioritize supporting people using substances during and after pregnancy to prevent death and improve quality of life for pregnant and postpartum people. SignificanceWhat is Already Known on this Subject? Maternal mortality rates have been increasing across the U.S. Substance use and overdoses are leading causes of death among pregnant and postpartum people. Return to use in the postpartum period following abstinence during pregnancy is common. New Mexico has some of the highest rates of death attributed to alcohol use, and experiences high rates of substance use.What does this study add? This study provides background on risk factors for Substance Use Disorder (SUD)-related death among pregnant and postpartum people in New Mexico. It explores experiences with mental health treatments and social stressors, and substance use patterns among pregnant and postpartum people with SUD-related deaths.
引用
收藏
页码:23 / 33
页数:11
相关论文
共 47 条
  • [31] Motor vehicle crashes and maternal mortality in New Mexico: The significance of seat belt use
    Schiff, M
    Albers, L
    McFeeley, P
    WESTERN JOURNAL OF MEDICINE, 1997, 167 (01): : 19 - 22
  • [32] Terrorism, civil war and related violence and substance use disorder morbidity and mortality: A global analysis
    Kerridge B.T.
    Khan M.R.
    Rehm J.
    Sapkota A.
    Journal of Epidemiology and Global Health, 2014, 4 (1) : 61 - 72
  • [33] Rural and urban patterns of severe injuries and hospital mortality in Australia: An analysis of the Australia New Zealand Trauma Registry: 2015-2019
    Heathcote, Katharine
    Devlin, Anna
    McKie, Emily
    Cameron, Peter
    Earnest, Arul
    Morgan, Geoff
    Gardiner, Ben
    Campbell, Don
    Wullschleger, Martin
    Warren, Jacelle
    INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED, 2022, 53 (06): : 1893 - 1903
  • [34] Intoxication related to substances use in patients presenting to Ain Shams University Poisoning Treatment Center, Cairo, Egypt (2015-2019)
    Azab, Sonya M. S.
    Tawfik, Hany
    Hayes, Bryan D.
    DRUG AND ALCOHOL REVIEW, 2022, 41 (05) : 1109 - 1118
  • [35] Increases in primary opioid use disorder diagnoses co-occurring with anxiety or depressive disorder diagnoses in mental health treatment in the United States, 2015-2019
    Ware, Orrin D.
    Ellis, Jennifer D.
    Strain, Eric C.
    Antoine, Denis G.
    Martinez, Suky
    Bergeria, Cecelia L.
    DRUG AND ALCOHOL DEPENDENCE, 2023, 253
  • [36] Sexual Orientation, Mental Illness, and Substance Use Disorders among Justice-Involved Individuals: Evidence from the National Survey of Drug Use and Health, 2015-2019
    Ramakrishnan, Abinaya
    Gonzales, Gilbert
    JOURNAL OF MENTAL HEALTH POLICY AND ECONOMICS, 2022, 25 : S25 - S25
  • [37] Prescription Opioid Misuse, Comorbid Substance Use, and Suicidal Behaviors Among US Young Adults: Findings from 2015-2019 National Survey on Drug Use and Health
    Oh, Seungbin
    Liu, Cindy
    Kitchen, Madison
    Hahm, Hyeouk
    SUBSTANCE USE & MISUSE, 2025, 60 (02) : 195 - 201
  • [38] Associations Between Receipt of Government Assistance and Past-Year Substance Use Treatment Utilization Among People With Alcohol or Drug Use Disorders in the United States, 2015-2019
    Gutkind, Sarah
    Philbin, Morgan
    Mauro, Pia
    DRUG AND ALCOHOL DEPENDENCE, 2024, 260
  • [39] A cascade of care for alcohol use disorder: Using 2015-2019 National Survey on Drug Use and Health data to identify gaps in past 12-month care
    Mintz, Carrie M.
    Hartz, Sarah M.
    Fisher, Sherri L.
    Ramsey, Alex T.
    Geng, Elvin H.
    Grucza, Richard A.
    Bierut, Laura J.
    ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH, 2021, 45 (06): : 1276 - 1286
  • [40] Epidemiology of Gunshot-Related Spinal Injuries and Related Risk Factors for In-Hospital Mortality in the United States from 2015-2019: A National Trauma Data Bank Analysis
    Sherrod, Brandon A.
    Young, Jason B.
    Wilkerson, Christopher G.
    Bisson, Erica F.
    Dailey, Andrew T.
    Mazur, Marcus D.
    JOURNAL OF NEUROTRAUMA, 2024, 41 (9-10) : 1112 - 1121